Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Beule, Dieter Dr. (2) Blankenstein, Thomas Prof. Dr. (27) Daniel, Peter Prof. Dr. (1) Kammertöns, Thomas Dr. (6) Keller, Ulrich Dr. med. (1) Kieback, Elisa Dr. (2) Kopp, Joachim Dr. (2) Mertins, Philipp Dr. (2) Pezzutto, Antonio Prof. Dr. (3) Poncette, Lucia (1) Popp, Oliver Dr. (2) Rahn, Hans-Peter Dr. (1) Rhein, Simone Dr. (1) Rosenberger, Leonie Milena (1) Schlag, Peter M. Prof. Dr. (1) Willimsky, Gerald Dr. (9) (-) Bunse, Mario Dr. (1) (-) Leisegang, Matthias Prof. Dr. rer. nat. (4) (-) Uckert, Wolfgang Prof. Dr. (6) 2003 (4) 2004 (1) 2005 (3) 2006 (1) 2007 (3) (-) 2008 (1) (-) 2010 (1) (-) 2011 (2) 2014 (1) 2015 (2) (-) 2016 (2) 2017 (1) 2018 (3) 2020 (1) (-) 2022 (1) AG Müller/Dechend (ECRC) (1) Bioinformatics and Omics Data Science (1) Biomedical Image Analysis (1) Cellular Neurosciences (5) Computational methodologies and omic analytics (1) Computational Regulatory Genomics (1) Experimental Ultrahigh-Field MR (6) Genetics of Metabolic and Reproductive Disorders (3) Genome Engineering & Disease Models (3) Genomics (6) Hypertension-caused End-Organ Damage (1) Hypertension-Mediated End-Organ Damage (1) Immune Mechanisms and Human Antibodies (1) Immune Regulation and Cancer (5) Magnetic Resonance (6) Microenvironmental Regulation in Autoimmunity and Cancer (5) Mobile DNA (3) (-) Molecular Immunology and Gene Therapy (7) Proteome Dynamics (3) RNA Biology and Posttranscriptional Regulation (14) Systems Biology of Gene Regulatory Elements (2) Transgenics (3) Translational Bioinformatics (7) Translational Tumorimmunology (2) 7 Results: Active Filter: Bunse, Mario Dr.Leisegang, Matthias Prof. Dr. rer. nat.Uckert, Wolfgang Prof. Dr.Molecular Immunology and Gene Therapy20082010201120162022 Sort: Result score Newest to oldest Oldest to newest January 15, 2008 / Proc Natl Acad Sci U S A A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer E. Kieback J. Charo D. Sommermeyer T. Blankenstein W. Uckert January 15, 2011 / Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens April 15, 2010 / Clin Cancer Res T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapy M. Leisegang A. Turqueti-Neves B. Engels T. Blankenstein D.J. Schendel W. Uckert E. Noessner July 28, 2011 / Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein March 01, 2016 / J Clin Invest Targeting human melanoma neoantigens by T cell receptor gene therapy M. Leisegang T. Kammertoens W. Uckert T. Blankenstein May 17, 2016 / Immunity Thymus-derived regulatory T cells are positively selected on natural self-antigen through cognate interactions of high functional avidity E. Kieback E. Hilgenberg U. Stervbo V. Lampropoulou P. Shen M. Bunse Y. Jaimes P. Boudinot A. Radbruch U. Klemm A.A. Kühl R. Liblau N. Hoevelmeyer S.M. Anderton W. Uckert S. Fillatreau August 01, 2022 / Cytotherapy Rapid single-cell identification of Epstein-Barr virus-specific T-cell receptors for cellular therapy M.F. Lammoglia Cobo C. Welters L. Rosenberger M. Leisegang K. Dietze C. Pircher L. Penter R. Gary L. Bullinger A. Takvorian A. Moosmann K. Dornmair T. Blankenstein T. Kammertöns A. Gerbitz L. Hansmann
January 15, 2008 / Proc Natl Acad Sci U S A A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer E. Kieback J. Charo D. Sommermeyer T. Blankenstein W. Uckert
January 15, 2011 / Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens
April 15, 2010 / Clin Cancer Res T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapy M. Leisegang A. Turqueti-Neves B. Engels T. Blankenstein D.J. Schendel W. Uckert E. Noessner
July 28, 2011 / Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein
March 01, 2016 / J Clin Invest Targeting human melanoma neoantigens by T cell receptor gene therapy M. Leisegang T. Kammertoens W. Uckert T. Blankenstein
May 17, 2016 / Immunity Thymus-derived regulatory T cells are positively selected on natural self-antigen through cognate interactions of high functional avidity E. Kieback E. Hilgenberg U. Stervbo V. Lampropoulou P. Shen M. Bunse Y. Jaimes P. Boudinot A. Radbruch U. Klemm A.A. Kühl R. Liblau N. Hoevelmeyer S.M. Anderton W. Uckert S. Fillatreau
August 01, 2022 / Cytotherapy Rapid single-cell identification of Epstein-Barr virus-specific T-cell receptors for cellular therapy M.F. Lammoglia Cobo C. Welters L. Rosenberger M. Leisegang K. Dietze C. Pircher L. Penter R. Gary L. Bullinger A. Takvorian A. Moosmann K. Dornmair T. Blankenstein T. Kammertöns A. Gerbitz L. Hansmann